Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Excipient makers raise concern over EU risk assessment deadline

This article was originally published in SRA

Executive Summary

Excipient producers and distributors have warned that the European Commission's deadline of 21 March 2016 by which all drug makers in the EU must carry out a formal risk assessment of the excipients they use in their medicinal products is too short and may jeopardize the availability of high quality excipients that have been in use for many years1.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS118252

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel